This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rosell, R. Articles by Barnadas, A. Search for Related Content PubMed PubMed Citation Articles by Rosell, R. Articles by Barnadas, A.

Genetic Susceptibility Associated with Rare HRAS1 Variable Number of Tandem Repeats Alleles in Spanish Non-Small Cell Lung Cancer Patients¹

Laboratory of Molecular Biology of Cancer [R. R., R. C., M. M., L. N.] and Medical Oncology Service [R. R., J. M., M. G., A. B.], University Hospital Germans Trias i Pujol, 08916 Badalona, Barcelona; and Statistical Department [J. J. S.], School of Medicine, Free University of Madrid, 28029 Madrid, Spain

The highly polymorphic HRAS1 variable number of tandem repeats (VNTR), which maps 1 kb downstream from the human H-ras1 gene, has been described as an inherited predisposing factor in many human cancers. Here, we investigated the association between the presence of rare HRAS1 minisatellite alleles and lung cancer in the population studied. Four hundred sixty-six HRAS1 VNTR alleles from 233 lung cancer patients and 892 alleles from 446 unaffected controls were typed using PCR-long agarose gel electrophoresis assay of peripheral blood lymphocyte DNA. Rare alleles were differentiated from common alleles (a1, a2, a3, and a4) by shifts in electrophoretic mobility. Odds ratio was calculated to evaluate increased risk of lung cancer associated to the presence of rare HRAS1 alleles. A higher percentage of rare HRAS1 VNTR alleles in lung cancer patients than in unaffected controls (32.7 versus 21.9%) was confirmed. The presence of rare alleles was associated with an increased risk of lung cancer (odds ratio = 1.68; P 0.0001), indicating a genetic predisposition to lung cancer. No differences based on other clinicopathological variables were observed. Furthermore, a meta-analysis showed a higher distribution of rare alleles in our study of Caucasian Spaniards than was found in other studies of American and Northern European Caucasian populations. We conclude that the presence of rare HRAS1 VNTR alleles may be an inherited predisposing factor in lung cancer. This presence can be easily determined from peripheral blood samples by PCR-based methods. Furthermore, interracial variations in allele frequencies and variations between Caucasian subpopulations suggest that genetic variations may be involved in susceptibility to lung oncogenesis, especially in certain ethnic populations.

This article has been cited by other articles:

				P. A. Jauert and D. T. Kirkpatrick Length and Sequence Heterozygosity Differentially Affect HRAS1 Minisatellite Stability During Meiosis in Yeast Genetics, June 1, 2005; 170(2): 601 - 612. [Abstract] [Full Text] [PDF]

				R. M. Tamimi, S. E. Hankinson, S. Ding, V. Gagalang, G. P. Larson, D. Spiegelman, G. A. Colditz, T. G. Krontiris, and D. J. Hunter The HRAS1 Variable Number of Tandem Repeats and Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1528 - 1530. [Abstract] [Full Text] [PDF]

				J. A. Langdon and J. A.L. Armour Evolution and population genetics of the H-ras minisatellite and cancer predisposition Hum. Mol. Genet., April 15, 2003; 12(8): 891 - 900. [Abstract] [Full Text] [PDF]

				L. M. Pierce, L. Sivaraman, W. Chang, A. Lum, T. Donlon, A. Seifried, L. R. Wilkens, A. F. Lau, and L. Le Marchand Relationships of TP53 Codon 72 and HRAS1 Polymorphisms with Lung Cancer Risk in an Ethnically Diverse Population Cancer Epidemiol. Biomarkers Prev., November 1, 2000; 9(11): 1199 - 1204. [Abstract] [Full Text]

				J. L. Hopper, F. A. Firgaira, G. S. Dite, G. G. Giles, M. R. E. McCredie, M. C. Southey, D. J. Venter, R. Seshadri, and C. R. E. McEvoy RESPONSE: Re: HRAS1 Rare Minisatellite Alleles and Breast Cancer in Australian Women Under Age Forty Years J Natl Cancer Inst, May 3, 2000; 92(9): 756 - 757. [Full Text] [PDF]